Eiger Investor News

Home»Eiger Investor News
17 04, 2019

Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock – 4/17/2019

2019-04-18T13:23:00+00:00

Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock - 4/17/2019 Palo Alto, Calif., April 17, 2019, Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR) today announced the pricing of an underwritten public offering of 4,500,000 shares of its common stock at a price to the public of $11.00 per share. All of the shares are being [...]

Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock – 4/17/20192019-04-18T13:23:00+00:00
17 04, 2019

Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock 4/17/2019

2019-04-18T13:18:13+00:00

Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock 4/17/2019 Palo Alto, Calif., April 17, 2019, Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in the offering are to be sold by Eiger. In [...]

Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock 4/17/20192019-04-18T13:18:13+00:00